Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Zenlabs Ethica's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Zenlabs Ethica's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Zenlabs Ethica was 0.18. The lowest was 0.12. And the median was 0.15.
BOM:530697's Dividend Payout Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: 0.43 * Ranked among companies with meaningful Dividend Payout Ratio only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Zenlabs Ethica (BOM:530697) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Zenlabs Ethica Dividend Payout Ratio Related Terms
Zenlabs Ethica Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Zenlabs Ethica's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530697 vs MCK, CAH, COR: Dividend Payout Ratio Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica Dividend Payout Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Zenlabs Ethica's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenlabs Ethica (BOM:530697) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Zenlabs Ethica and its competitors. Over the past decade, Zenlabs Ethica's Dividend Payout Ratio has ranged from 0.12 to 0.18. According to the industry distribution chart, Zenlabs Ethica ranks #999999 out of 62 companies in the Medical Distribution industry.
Is Zenlabs Ethica's Dividend Payout Ratio too high?
Zenlabs Ethica's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 0.18. Based on the distribution chart, Zenlabs Ethica ranks #999999 out of 62 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Zenlabs Ethica has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Dividend Payout Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #999999 out of 62 companies for Dividend Payout Ratio. This places Zenlabs Ethica in the lower half of its industry. The industry median Dividend Payout Ratio is 0.43. Historically, Zenlabs Ethica's own Dividend Payout Ratio has ranged from 0.12 to 0.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.43, based on 62 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Fairly Valued. The stock's GF Value™ is ₹29.21, compared to a current price of ₹32.21 — trading 10.3% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Zenlabs Ethica's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹32.21 is trading 10.3% above its estimated GF Value™ of ₹29.21.
GuruFocus considers Zenlabs Ethica to be Fairly Valued.
Key valuation signals for BOM:530697:
Dividend Payout Ratio: 0.00
GF Value™: ₹29.21 vs. price of ₹32.21 (10.3% above fair value)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
54GF Score
Get the complete analysis for BOM:530697
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 
